| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Departments of Neurology (Drs. Thaisetthawatkul, Logigian, and Herrmann) and Pathology (Dr. Herrmann), University of Rochester Medical Center, NY.
Address correspondence and reprint requests to Dr. David N. Herrmann, Department of Neurology, Box 673, 601 Elmwood Ave., University of Rochester Medical Center, Rochester, NY 14642; e-mail: david_herrmann{at}urmc.rochester.edu
Objective: To assess distal compound muscle action potential (DCMAP) duration as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathy (CIDP).
Background: Current electrodiagnostic criteria for CIDP have high specificity but limited sensitivity. Prolonged DCMAP duration has been reported in acute inflammatory demyelinating polyneuropathy. The authors have compared DCMAP duration in patients with CIDP, diabetic polyneuropathy (DP), ALS, and musculoskeletal pain syndrome (MSP) to determine whether it enhances the sensitivity of electrodiagnostic criteria for CIDP.
Methods: Data from 23 CIDP, 34 DP, 34 ALS, and 54 MSP patients were reviewed. The time interval between onset of the first negative peak and return to baseline of the last negative peak of the DCMAP was calculated for each nerve. To distinguish CIDP from DP, ALS, and MSP, optimal cutoff values for DCMAP duration were achieved with receiver-operating characteristic curves. The sensitivity and specificity of these cutoff values were compared with each of four sets of electrodiagnostic criteria for CIDP.
Results: Mean DCMAP duration in CIDP was significantly longer than in DP, ALS, and MSP. The sensitivity of existing electrodiagnostic criteria for CIDP ranged between 0.43 and 0.61. Their specificity vs DP or ALS was 0.91 to 1. Using DCMAP duration of 
9 milliseconds for any of four motor nerves yielded a sensitivity of 0.78 for CIDP and specificity of 0.94 vs DP or ALS. Adding DCMAP duration criteria to any one of the three accepted criteria enhanced their sensitivity with little sacrifice of specificity.
Conclusion: Quantitation of DCMAP dispersion shows promise as a sensitive and specific adjunctive electrodiagnostic criterion for CIDP.
This article has been cited by other articles:
|
|
 |
|
  Y A Rajabally, G Nicolas, F Pieret, P Bouche, and P Y K Van den Bergh Validity of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy: a multicentre European study J. Neurol. Neurosurg. Psychiatry, December 1, 2009; 80(12): 1364 - 1368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Jann, M A Bramerio, D Facchetti, and R Sterzi Intravenous immunoglobulin is effective in patients with diabetes and with chronic inflammatory demyelinating polyneuropathy: long term follow-up J. Neurol. Neurosurg. Psychiatry, January 1, 2009; 80(1): 70 - 73. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 The French CIDP Study Group Recommendations on diagnostic strategies for chronic inflammatory demyelinating polyradiculoneuropathy Postgrad. Med. J., July 1, 2008; 84(993): 378 - 381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
The French CIDP Study Group Recommendations on diagnostic strategies for chronic inflammatory demyelinating polyradiculoneuropathy J. Neurol. Neurosurg. Psychiatry, February 1, 2008; 79(2): 115 - 118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F A A Gondim, E A De Sousa, N Latov, H W Sander, R L Chin, and T H Brannagan Anti-MAG/SGPG associated neuropathy does not commonly cause distal nerve temporal dispersion J. Neurol. Neurosurg. Psychiatry, August 1, 2007; 78(8): 902 - 904. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. H. Van Asseldonk, L. H. Van den Berg, G. H. Wieneke, J. H. J. Wokke, and H. Franssen Criteria for conduction block based on computer simulation studies of nerve conduction with human data obtained in the forearm segment of the median nerve. Brain, September 1, 2006; 129(Pt 9): 2447 - 2460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Sommer, S. Koch, M. Lammens, A. Gabreels-Festen, G. Stoll, and K. V. Toyka Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP Neurology, December 27, 2005; 65(12): 1924 - 1929. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. T. H. Van Asseldonk, L. H. Van den Berg, S. Kalmijn, J. H. J. Wokke, and H. Franssen Criteria for demyelination based on the maximum slowing due to axonal degeneration, determined after warming in water at 37{degrees}C: diagnostic yield in chronic inflammatory demyelinating polyneuropathy Brain, April 1, 2005; 128(4): 880 - 891. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Koller, B. C. Kieseier, S. Jander, and H.-P. Hartung Chronic Inflammatory Demyelinating Polyneuropathy N. Engl. J. Med., March 31, 2005; 352(13): 1343 - 1356. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Magda, N. Latov, T. H. Brannagan III, L. H. Weimer, R. L. Chin, and H. W. Sander Comparison of Electrodiagnostic Abnormalities and Criteria in a Cohort of Patients With Chronic Inflammatory Demyelinating Polyneuropathy Arch Neurol, December 1, 2003; 60(12): 1755 - 1759. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. W. Sander and N. Latov Research criteria for defining patients with CIDP Neurology, April 22, 2003; 60(90083): S8 - 15. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
